Clinical Trials
- Myeloma
Daratumumab to Enhance Therapeutic Effectiveness of Revlimid in Smoldering Myeloma (DETER-SMM)
- Date03/16/2022
- Myeloma
A Phase 1, Open-label, Dose Finding Study of CC-93269, a BCMA X CD3 T Cell Engaging Antibody, in Subjects With Relapsed and Refractory Multiple Myeloma.
- Date08/27/2020
- Diseases of the Respiratory Systems
Evaluation of Efficacy and Safety of PLN-74809 in Patients With Idiopathic Pulmonary Fibrosis
- Ages40 years and older
- GenderBoth
- Date03/30/2022
- Asthma, Lung
Tezepelumab COPD Exacerbation Study (COURSE)
- Ages40 years - 80 years
- GenderBoth
- Date01/08/2020
- Immune System
Pathogenic Wnt-beta catenin target genes in macrophages and fibrosis
- Date06/01/2019
- Lung
Saracatinib (AZD0530) in the Treatment of Patients with Idiopathic Pulmonary Fibrosis
- Ages40 years and older
- GenderBoth
- Date02/26/2021
- Blood Disorders, Infectious Disease
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis (CLOVERS)
- Ages18 years and older
- GenderBoth
- Date11/05/2018
- Heart/Cardiovascular
Network for Cardiothoracic Surgical Investigations in Cardiovascular Medicine: Anticoagulation for New-Onset Post-Operative Atrial Fibrillation after CABG (PACES)
- Ages18 years and older
- GenderBoth
- Date03/01/2021
- Lung, Diseases of the Respiratory Systems
Safety, Tolerability, Kinetics, and Repeatability of the Novel LPA1 PET Ligand 18F-BMS-986327
- Ages18 years and older
- GenderBoth
- Date10/01/2019
- Women's Health, COVID-19 Inpatient, COVID-19 Outpatient
I-SPY COVID TRIAL: An Adaptive Platform Trial to Reduce Mortality and Ventilator Requirements for Critically Ill Patients
- Ages18 years and older
- GenderBoth
- Date10/08/2020